Original Query: ALL
Previous Study | Return to List | Next Study

PK Study of Pregabalin GLARS Tablet 150mg and IR Formulation After Multiple Dosing Under Fed Condition in Healthy Male Subjects (GLA5PR-102)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01638273
Recruitment Status : Completed
First Posted : July 11, 2012
Last Update Posted : November 13, 2014
Information provided by (Responsible Party):
GL Pharm Tech Corporation

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : July 2014
  Study Completion Date : November 2014